Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial

Author: Derosa Giuseppe   Salvadeo Sibilla A. T.   D’Angelo Angela   Ferrari Ilaria   Mereu Roberto   Palumbo Ilaria   Maffioli Pamela   Randazzo Sabrina   Cicero Arrigo F. G.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.25, Iss.3, 2009-03, pp. : 607-615

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content